Average Co-Inventor Count = 6.15
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University Health Network (27 from 291 patents)
28 patents:
1. 12325700 - Crystal form S4 of the PLK4 inhibitor (1R,2S)-(e)-2-(3-(4-((cis-2,6-dimethylmorpholino)methyl)styryl)-1 h-imidazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one fumarate
2. 11878980 - Solid forms of TTK inhibitor
3. 11104681 - Solid forms of TTK inhibitor
4. 11059832 - HPK1 inhibitors and methods of using same
5. 10875863 - RIPK2 inhibitors and method of treating cancer with same
6. 10584130 - Solid forms of TTK inhibitor
7. 10570143 - Pyrazolopyrimidine compounds
8. 10501474 - HPK1 inhibitors and methods of using same
9. RE47731 - Kinase inhibitors and method of treating cancer with same
10. 10358436 - Kinase inhibitors and method of treating cancer
11. 10239881 - RIPK2 inhibitors and method of treating cancer with same
12. 10167289 - Pyrazolopyrimidine compounds
13. 10106545 - Pyrazolopyrimidine compounds
14. 10077255 - Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2′-ones
15. 9907800 - Kinase inhibitors and method of treating cancer